Adrian Adams

Mr. Adrian Adams is a Chairman at Akebia Therapeutics, Inc. and a Chairman at Talphera, Inc. Mr. Adams was previously employed as a Chairman, President & Chief Executive Officer by Impel Pharmaceuticals, Inc., a Chief Executive Officer & Director by Aralez Pharmaceuticals, Inc., a Chief Executive Officer & Director by Aralez Pharmaceuticals Plc, a Chief Executive Officer & Director by POZEN, Inc., a President, Chief Executive Officer & Director by Auxilium Pharmaceuticals LLC, a Chairman & Chief Executive Officer by Neurologix, Inc., a President, Chief Executive Officer & Director by Inspire Pharmaceuticals, Inc., an Independent Director by Amylin Pharmaceuticals, Inc., a President & Chief Executive Officer by Sunovion Pharmaceuticals, Inc., a President & Chief Executive Officer by KOS Pharmaceuticals, Inc., a President & Chief Executive Officer by Novartis Pharmaceuticals UK Ltd., a Director-Sales & Marketing by AstraZeneca, Inc., and a President & Chief Executive Officer by Smithkline Beecham Plc.
He also served on the board at Neurocrine Biosciences, Inc. and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from The University of Manchester and an undergraduate degree from the University of Salford.